OpenVSafe by OpenVAERS
Search V-safe

CAN-32999-91910

2 vaccinations 5 coded responses 20 check-ins 5 free-text entries 0 call cases
Sex
Male
Age at first dose
26-30
ZIP prefix
200 / DC
Registered
2021-01-04
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-04
    Registered in v-safe
  2. 2021-01-04
    Dose 1 — Moderna
  3. 2021-01-04
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Feeling cold, Hyperhidrosis — Feeling: Good · Site: Pain · Chills
    Free text: Cold sweats
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-11
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-18
    Survey response — day 14, dose 1
    MedDRA: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth — Feeling: Good
    Free text: Delayed injection site reaction at approx day 8 with fist sized area of tenderness, erythema, induration, and warmth at location of inoculation. Resolved by day 10. No other associated symptoms. Pain was 4/10, did not require OTC pain control.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-25
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-01
    Dose 2 — Moderna
  13. 2021-02-01
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-02-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling, Itching · Chills, Joint pains, Muscle or body aches, Nausea, Rash, not including the immediate area around the injection site
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Itching · Muscle or body aches, Diarrhea
    Adult check-in
  17. 2021-02-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Epistaxis — Feeling: Good · Site: Pain · Muscle or body aches
    Free text: Since second dose: Nosebleeds 1-2 times a day that take a couple of minutes before they stop. No other associated sxs
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-10
    Survey response — day 7, dose 2
    MedDRA: Epistaxis — Feeling: Good
    Free text: Nosebleeds have stopped! No bruising
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-18
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-22
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-01
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-15
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-04Moderna
22021-02-01Moderna

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-05

Systemic reaction (other): Cold sweats

Release 2 — day 14, dose 1

2021-01-18

Symptoms: Delayed injection site reaction at approx day 8 with fist sized area of tenderness, erythema, induration, and warmth at location of inoculation. Resolved by day 10. No other associated symptoms. Pain was 4/10, did not require OTC pain control.

Release 3 — days 1–6 daily, dose 2

2021-02-03

Systemic reaction (other): Lymphadenopathy

2021-02-06

Systemic reaction (other): Since second dose: Nosebleeds 1-2 times a day that take a couple of minutes before they stop. No other associated sxs

Release 4 — day 7, dose 2

2021-02-10

Systemic reaction (other): Nosebleeds have stopped! No bruising

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDInjection site erythema ✓ ✓ ✓
SDInjection site induration ✓ ✓ ✓
SDInjection site pain ✓ ✓ ✓
SDInjection site warmth ✓ ✓ ✓
SROCold sweat ○ ○ ○
SROEpistaxis ✓ ✓ ✓
SROFeeling cold ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release